Ad is loading...
NEMRX vs VEMAX
NEMRX vs VEMAX Comparison
Open Charts NEMRX vs VEMAX
Neuberger Berman Emerg Mkts Eq R3
Price$20.68
Change-$0.03 (-0.14%)
VolumeN/A
Net Assets188.74M
Vanguard Emerging Mkts Stock Idx Adm
Price$38.29
Change-$0.10 (-0.26%)
VolumeN/A
Net Assets112.08B
NEMRX vs VEMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
NEMRX vs. VEMAX commentary
May 09, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEMRX is a Buy and VEMAX is a Buy.
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 112B vs. NEMRX (189M). VEMAX pays higher dividends than NEMRX: VEMAX (3.07) vs NEMRX (0.00). NEMRX was incepted earlier than VEMAX: NEMRX (15 years) vs VEMAX (19 years). NEMRX (2.25) is less costly to investors than VEMAX (0.13). NEMRX is a more actively managed with annual turnover of: 111.00 vs. VEMAX (8.00). NEMRX has a lower initial minimum investment than VEMAX: NEMRX (0) vs VEMAX (3000). NEMRX annual gain was more profitable for investors over the last year : 10.77 vs. VEMAX (9.16). VEMAX return over 5 years is better than : 39.83 vs. NEMRX (23.35).
| NEMRX | VEMAX | NEMRX / VEMAX | |
| Total Expense Ratio | 1.95 | 0.13 | 1,500% |
| Annual Report Gross Expense Ratio | 2.25 | 0.13 | 1,731% |
| Fund Existence | 15 years | 19 years | - |
| Gain YTD | 6.218 | 4.468 | 139% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 189M | 112B | 0% |
| Annual Yield % from dividends | 0.00 | 3.07 | - |
| Returns for 1 year | 10.77 | 9.16 | 118% |
| Returns for 3 years | 18.59 | 21.24 | 88% |
| Returns for 5 years | 23.35 | 39.83 | 59% |
| Returns for 10 years | 23.99 | 25.87 | 93% |
View a ticker or compare two or three
VS
VS
Ad is loading...